Respreeza European Union - English - EMA (European Medicines Agency)

respreeza

csl behring gmbh - alpha1-proteinase inhibitor (human) - genetic diseases, inborn, lung diseases - antihemorrhagics, - respreeza is indicated for maintenance treatment, to slow the progression of emphysema in adults with documented severe alpha1-proteinase inhibitor deficiency (e.g. genotypes pizz, piz(null), pi(null,null), pisz). patients are to be under optimal pharmacologic and non-pharmacologic treatment and show evidence of progressive lung disease (e.g. lower forced expiratory volume per second (fev1) predicted, impaired walking capacity or increased number of exacerbations) as evaluated by a healthcare professional experienced in the treatment of alpha1-proteinase inhibitor deficiency.,

Meropenem AptaPharma 500mg Powder for solution for injection/infusion Malta - English - Medicines Authority

meropenem aptapharma 500mg powder for solution for injection/infusion

apta medica internacional d.o.o likozarjeva ulica 6, 1000 ljubljana, , slovenia - meropenem - powder for solution for infusion or injection - meropenem 500 mg - antibacterials for systemic use

Meropenem AptaPharma 1000mg Powder for solution for injection/infusion Malta - English - Medicines Authority

meropenem aptapharma 1000mg powder for solution for injection/infusion

apta medica internacional d.o.o likozarjeva ulica 6, 1000 ljubljana, , slovenia - meropenem - powder for solution for infusion or injection - meropenem 1000 mg - antibacterials for systemic use

Ampicillin/sulbactam AptaPharma 1 g/0,5 g powder for solution for injection/infusion Malta - English - Medicines Authority

ampicillin/sulbactam aptapharma 1 g/0,5 g powder for solution for injection/infusion

apta medica internacional d.o.o likozarjeva ulica 6, 1000 ljubljana, , slovenia - a, s - solution for injection/infusion - ampicillin sodium 1 g sulbactam sodium 0.5 g - antibacterials for systemic use

Ampicillin/sulbactam AptaPharma 2 g/1 g powder for solution for injection/infusion Malta - English - Medicines Authority

ampicillin/sulbactam aptapharma 2 g/1 g powder for solution for injection/infusion

apta medica internacional d.o.o likozarjeva ulica 6, 1000 ljubljana, , slovenia - a, s - powder for solution for injection/infusion - ampicillin sodium 2 g sulbactam sodium 1 g - antibacterials for systemic use

Vancomycin AptaPharma 500 mg powder for concentrate for solution for infusion Malta - English - Medicines Authority

vancomycin aptapharma 500 mg powder for concentrate for solution for infusion

apta medica internacional d.o.o likozarjeva ulica 6, 1000 ljubljana, , slovenia - vancomycin - powder for concentrate for solution for infusion - vancomycin 50 mg/ml - antibacterials for systemic use

Vancomycin AptaPharma 1000 mg powder for concentrate for solution for infusion Malta - English - Medicines Authority

vancomycin aptapharma 1000 mg powder for concentrate for solution for infusion

apta medica internacional d.o.o likozarjeva ulica 6, 1000 ljubljana, , slovenia - vancomycin - powder for concentrate for solution for infusion - vancomycin 50 mg/ml - antibacterials for systemic use

Hizentra European Union - English - EMA (European Medicines Agency)

hizentra

csl behring gmbh - human normal immunoglobulin (scig) - immunologic deficiency syndromes - immune sera and immunoglobulins, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4.4).- secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of

Idelvion European Union - English - EMA (European Medicines Agency)

idelvion

csl behring gmbh - albutrepenonacog alfa - hemophilia b - antihemorrhagics, - treatment and prophylaxis of bleeding in patients with haemophilia b (congenital factor ix deficiency).